Associated Banc Corp Agios Pharmaceuticals, Inc. Transaction History

Associated Banc Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$44.23 - $57.5 $2,698 - $3,507	-61 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$33.21 - $46.54 $1,992 - $2,792	60 Added 6000.0%	61 $3,000
Q3 2020 Nov 12, 2020	SELL	$33.87 - $55.93 $1,591 - $2,628	-47 Reduced 97.92%	1 $0
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $137 - $213	4 Added 9.09%	48 $3,000
Q1 2020 May 14, 2020	BUY	$31.52 - $53.81 $1,386 - $2,367	44 New	44 $2,000

233

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.9B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

Stay updated on Associated Banc Corp with notifications on news.